Skip to main content
Top
Published in: International Journal of Hematology 1/2008

01-01-2008 | Case Report

Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH

Authors: Yoichiro Tsuji, Kazuhiro Kogawa, Kohsuke Imai, Hirokazu Kanegane, Junichiro Fujimoto, Shigeaki Nonoyama

Published in: International Journal of Hematology | Issue 1/2008

Login to get access

Abstract

We report a 1-year-old girl with Evans syndrome coexisting with histologically confirmed Langerhans cell histiocytosis (LCH) affecting the cervical lymph nodes, liver, and spleen. Anti-cardiolipin antibody, anti-SS-A antibody, and anti-SS-B antibody as well as a direct antiglobulin test and platelet-associated IgG were all positive at the onset, and these autoantibodies became negative with the resolution of LCH by chemotherapy. Serum T-helper-2 (Th2) cytokine levels such as those of interleukin (IL)-6 and IL-10 were high whereas those of Th1 cytokines such as IL-2 and interferon-gamma were low at the onset, and this cytokine imbalance was normalized during the resolution of LCH. These results suggest that cytokine imbalance due to LCH led to multiple autoimmune phenomena in the present patient.
Literature
2.
go back to reference Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12(2):247–58.PubMedCrossRef Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12(2):247–58.PubMedCrossRef
3.
go back to reference Teachey DT, Manno CS, Axsom KM, et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood. 2005;105(6):2443–8.PubMedCrossRef Teachey DT, Manno CS, Axsom KM, et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood. 2005;105(6):2443–8.PubMedCrossRef
4.
go back to reference Morimoto A, Ikushima S, Kinugawa N, et al. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study. Cancer. 2006;107(3):613–9.PubMedCrossRef Morimoto A, Ikushima S, Kinugawa N, et al. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study. Cancer. 2006;107(3):613–9.PubMedCrossRef
5.
go back to reference Gilcrease MZ, Rajan B, Ostrowski ML, et al. Localized thymic Langerhans’ cell histiocytosis and its relationship with myasthenia gravis. Immunohistochemical, ultrastructural, and cytometric studies. Arch Pathol Lab Med. 1997;121(2):134–8.PubMed Gilcrease MZ, Rajan B, Ostrowski ML, et al. Localized thymic Langerhans’ cell histiocytosis and its relationship with myasthenia gravis. Immunohistochemical, ultrastructural, and cytometric studies. Arch Pathol Lab Med. 1997;121(2):134–8.PubMed
6.
go back to reference Rachima CM, Cohen E, Iaina NL, et al. A case of Langerhans’-cell histiocytosis with membranous nephropathy. Am J Kidney Dis. 2004;43(2):e3–9.PubMedCrossRef Rachima CM, Cohen E, Iaina NL, et al. A case of Langerhans’-cell histiocytosis with membranous nephropathy. Am J Kidney Dis. 2004;43(2):e3–9.PubMedCrossRef
7.
go back to reference Robak T, Kordek R, Robak E, et al. Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide. Leuk Lymphoma. 2002;43(10):2041–6.PubMedCrossRef Robak T, Kordek R, Robak E, et al. Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide. Leuk Lymphoma. 2002;43(10):2041–6.PubMedCrossRef
8.
go back to reference Oliveira MC, Oliveira BM, Murao M, et al. Clinical course of autoimmune hemolytic anemia: an observational study. J Pediatr (Rio J). 2006;82(1):58–62.CrossRef Oliveira MC, Oliveira BM, Murao M, et al. Clinical course of autoimmune hemolytic anemia: an observational study. J Pediatr (Rio J). 2006;82(1):58–62.CrossRef
9.
go back to reference Maghnie M, Ghirardello S, De Bellis A, et al. Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clin Endocrinol (Oxf). 2006;65(4):470–8.CrossRef Maghnie M, Ghirardello S, De Bellis A, et al. Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clin Endocrinol (Oxf). 2006;65(4):470–8.CrossRef
10.
go back to reference Savasan S, Warrier I, Ravindranath Y. The spectrum of Evans’ syndrome. Arch Dis Child. 1997;77(3):245–8.PubMedCrossRef Savasan S, Warrier I, Ravindranath Y. The spectrum of Evans’ syndrome. Arch Dis Child. 1997;77(3):245–8.PubMedCrossRef
11.
go back to reference Egeler RM, Favara BE, van Meurs M, et al. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood. 1999;94(12):4195–201.PubMed Egeler RM, Favara BE, van Meurs M, et al. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood. 1999;94(12):4195–201.PubMed
12.
go back to reference Barcellini W, Clerici G, Montesano R, et al. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol. 2000;111(2):452–60.PubMedCrossRef Barcellini W, Clerici G, Montesano R, et al. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol. 2000;111(2):452–60.PubMedCrossRef
Metadata
Title
Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH
Authors
Yoichiro Tsuji
Kazuhiro Kogawa
Kohsuke Imai
Hirokazu Kanegane
Junichiro Fujimoto
Shigeaki Nonoyama
Publication date
01-01-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-007-0007-x

Other articles of this Issue 1/2008

International Journal of Hematology 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine